JP Morgan Chase’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $749M | Sell |
3,520,438
-326,018
| -8% | -$64M | 0.04% | 346 |
|
|
2026
Q1 | $758M | Sell |
3,846,456
-299,440
| -7% | -$58.2M | 0.05% | 317 |
|
|
2025
Q4 | $719M | Sell |
4,145,896
-171,495
| -4% | -$31.2M | 0.05% | 324 |
|
|
2025
Q3 | $823M | Sell |
4,317,391
-14,269
| -0.3% | -$2.53M | 0.05% | 314 |
|
|
2025
Q2 | $778M | Buy |
4,331,660
+561,722
| +15% | +$97.6M | 0.05% | 318 |
|
|
2025
Q1 | $638M | Buy |
3,769,938
+1,336,025
| +55% | +$219M | 0.05% | 331 |
|
|
2024
Q4 | $367M | Buy |
2,433,913
+916,898
| +60% | +$143M | 0.03% | 462 |
|
|
2024
Q3 | $236M | Sell |
1,517,015
-18,505
| -1% | -$2.76M | 0.02% | 624 |
|
|
2024
Q2 | $210M | Sell |
1,535,520
-287,990
| -16% | -$39.4M | 0.02% | 635 |
|
|
2024
Q1 | $243M | Sell |
1,823,510
-44,220
| -2% | -$5.74M | 0.02% | 591 |
|
|
2023
Q4 | $258M | Sell |
1,867,730
-133,617
| -7% | -$17.6M | 0.02% | 544 |
|
|
2023
Q3 | $244M | Buy |
2,001,347
+538,377
| +37% | +$71.7M | 0.03% | 500 |
|
|
2023
Q2 | $206M | Buy |
1,462,970
+4,746
| +0.3% | +$654K | 0.02% | 557 |
|
|
2023
Q1 | $206M | Buy |
1,458,224
+1,154,403
| +380% | +$165M | 0.03% | 535 |
|
|
2022
Q4 | $47.5M | Sell |
303,821
-820
| -0.3% | -$118K | 0.01% | 1142 |
|
|
2022
Q3 | $37.4M | Buy |
304,641
+21,010
| +7% | +$2.77M | 0.01% | 1190 |
|
|
2022
Q2 | $37.7M | Sell |
283,631
-66,490
| -19% | -$9.06M | 0.01% | 1194 |
|
|
2022
Q1 | $47.9M | Sell |
350,121
-106,463
| -23% | -$14.8M | 0.01% | 1186 |
|
|
2021
Q4 | $79M | Buy |
456,584
+84,654
| +23% | +$12.9M | 0.01% | 991 |
|
|
2021
Q3 | $54M | Buy |
371,930
+12,197
| +3% | +$1.78M | 0.01% | 1138 |
|
|
2021
Q2 | $47.5M | Sell |
359,733
-51,799
| -13% | -$6.78M | 0.01% | 1248 |
|
|
2021
Q1 | $52.8M | Sell |
411,532
-1,466,463
| -78% | -$181M | 0.01% | 1139 |
|
|
2020
Q4 | $224M | Buy |
1,877,995
+194,810
| +12% | +$23.7M | 0.03% | 492 |
|
|
2020
Q3 | $191M | Sell |
1,683,185
-1,342,307
| -44% | -$159M | 0.03% | 493 |
|
|
2020
Q2 | $345M | Buy |
3,025,492
+53,902
| +2% | +$5.72M | 0.07% | 285 |
|
|
2020
Q1 | $239M | Buy |
2,971,590
+678,616
| +30% | +$70.3M | 0.06% | 317 |
|
|
2019
Q4 | $245M | Buy |
2,292,974
+415,812
| +22% | +$43.4M | 0.05% | 379 |
|
|
2019
Q3 | $201M | Buy |
1,877,162
+1,717,246
| +1,074% | +$176M | 0.04% | 438 |
|
|
2019
Q2 | $16.1M | Sell |
159,916
-112,495
| -41% | -$10.8M | ﹤0.01% | 1728 |
|
|
2019
Q1 | $24.5M | Sell |
272,411
-146,187
| -35% | -$12.7M | 0.01% | 1400 |
|
|
2018
Q4 | $34.9M | Buy |
418,598
+47,901
| +13% | +$4.49M | 0.01% | 1092 |
|
|
2018
Q3 | $40M | Buy |
370,697
+125,079
| +51% | +$13.7M | 0.01% | 1151 |
|
|
2018
Q2 | $27M | Buy |
245,618
+44,837
| +22% | +$4.67M | 0.01% | 1366 |
|
|
2018
Q1 | $20.1M | Sell |
200,781
-44,516
| -18% | -$4.56M | ﹤0.01% | 1502 |
|
|
2017
Q4 | $24.2M | Sell |
245,297
-652,455
| -73% | -$61.9M | 0.01% | 1443 |
|
|
2017
Q3 | $82.6M | Sell |
897,752
-25,997
| -3% | -$2.76M | 0.02% | 703 |
|
|
2017
Q2 | $103M | Buy |
923,749
+458,918
| +99% | +$48.5M | 0.02% | 608 |
|
|
2017
Q1 | $45.6M | Buy |
464,831
+105,852
| +29% | +$10.1M | 0.01% | 980 |
|
|
2016
Q4 | $33M | Sell |
358,979
-33,022
| -8% | -$2.85M | 0.01% | 1145 |
|
|
2016
Q3 | $33.2M | Buy |
392,001
+134,149
| +52% | +$11.3M | 0.01% | 1048 |
|
|
2016
Q2 | $21M | Buy |
257,852
+20,391
| +9% | +$1.55M | 0.01% | 1366 |
|
|
2016
Q1 | $17M | Buy |
237,461
+46,613
| +24% | +$3.13M | ﹤0.01% | 1439 |
|
|
2015
Q4 | $13.6M | Sell |
190,848
-17,013
| -8% | -$1.14M | ﹤0.01% | 1604 |
|
|
2015
Q3 | $12.8M | Buy |
207,861
+22,635
| +12% | +$1.58M | ﹤0.01% | 1568 |
|
|
2015
Q2 | $13.4M | Sell |
185,226
-129,542
| -41% | -$9.56M | ﹤0.01% | 1697 |
|
|
2015
Q1 | $24.2M | Buy |
314,768
+90,754
| +41% | +$6.5M | 0.01% | 1304 |
|
|
2014
Q4 | $15M | Sell |
224,014
-399,844
| -64% | -$25.2M | ﹤0.01% | 1661 |
|
|
2014
Q3 | $37.9M | Buy |
623,858
+389,598
| +166% | +$24M | 0.01% | 1059 |
|
|
2014
Q2 | $13.7M | Buy |
234,260
+62,844
| +37% | +$3.68M | ﹤0.01% | 1563 |
|
|
2014
Q1 | $9.93M | Sell |
171,416
-686,000
| -80% | -$36.8M | ﹤0.01% | 1728 |
|
|
2013
Q4 | $45.9M | Sell |
857,416
-204,824
| -19% | -$12.1M | 0.01% | 855 |
|
|
2013
Q3 | $65.6M | Sell |
1,062,240
-118,004
| -10% | -$7.06M | 0.02% | 692 |
|
|
2013
Q2 | $71.6M | Buy |
+1,180,244
| New | +$70.3M | 0.02% | 621 |
|
Other funds holding DGX
EIG
JP Morgan Chase's DGX Position: Q2 2026 in Review
JP Morgan Chase reduced its Quest Diagnostics (DGX) stake by 8.5% in Q2 2026, selling an estimated $64M and leaving 3,520,438 shares worth $749M. The position accounts for 0.04% of the portfolio, ranked #346.
JP Morgan Chase first reported a position in DGX in Q2 2013 and has held it in 53 quarters since. The position peaked at $823M in Q3 2025. 1,099 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- JP Morgan Chase held 3,520,438 shares of Quest Diagnostics worth $749M as of Q2 2026.
- JP Morgan Chase sold 326,018 Quest Diagnostics shares in Q2 2026, an estimated $64M.
- Quest Diagnostics made up 0.04% of JP Morgan Chase's portfolio in Q2 2026, its #346 holding.
- JP Morgan Chase first reported a position in Quest Diagnostics in Q2 2013 and has held it in 53 quarters since.
- JP Morgan Chase's Quest Diagnostics position peaked at $823M in Q3 2025.
- 1,099 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.